Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
Piramal Pharma Solutions announces the intent to acquire Ash Stevens
Wednesday, August 17, 2016Ash Stevens Inc a leading provider of global contract pharmaceutical drug substance development and active pharmaceutical ingredient API manufacturing services is pleased to announce that the company has been acquired by Piramal Pharma Solutions a wo...
Hedge funds made big changes at drug companies in second quarter
Tuesday, August 16, 2016For many prominent hedge fund managers who bet Pfizer Inc and Allergan Plc would merge to become the worlds biggest pharmaceuticals company the second quarter started with a thud that sent many in search of new opportunities John Griffins Blue Ridge...
Astrazeneca Closes Global Licencing Deal With Leo Pharma For Tralokinumab
Tuesday, August 16, 2016AstraZeneca said that it has completed the licensing agreement with LEO Pharma AS a specialist in dermatology care for the global licence to tralokinumab in skin diseases Tralokinumab is an IL monoclonal antibody that has completed a Phase IIb trial...
AcelRx Pharmaceuticals says ARX-04 phase 3 trial met primary endpoint
Tuesday, August 16, 2016AcelRx Pharmaceuticals Inc Overall ARX was well tolerated in study with of patients reporting no adverse events Topline results from singlearm openlabel phase sap trial which assessed ARX in patients with pain related to trauma or injury AcelRx Ph...
Scintilla Pharmaceuticals, a Subsidiary of Sorrento Therapeutics, Inc., to Acquire Semnur Pharmaceuticals
Tuesday, August 16, 2016Scintilla Pharmaceuticals Inc a subsidiary of Sorrento Therapeutics Inc has entered into a binding term sheet to acquire Semnur Pharmaceuticals Inc Semnur Scintillas lead program is resiniferatoxin RTX for the treatment of intractable cancer pain Se...
Biotech’s Resurgence May Cost Big Pharma
Friday, August 12, 2016There are signs that a new wave of deals is brewing in the biotech sector That is juicing shares and pushing up valuations Some likely buyers are Amgen Gilead Sciences and Merck which are among the large drugmakers who have said this year that they...
Jacobs Awarded Contract for Novartis Biotechnology Center Expansion in France
Friday, August 12, 2016Jacobs Engineering Group Inc JEC announced today it was awarded a contract to expand the Novartis Pharma SAS Biotechnology Center in Huningue France Under the terms of the agreement Jacobs is providing engineering procurement and construction manage...
AstraZeneca wins UK cost approval for longer use of heart drug
Friday, August 12, 2016Long term use of AstraZenecas blood thinner Brilinta has been recommended as a costeffective option for treating patients after a heart attack Britains healthcare cost watchdog NICE said on Friday Ticagrelor mg sold in Britain as Brilique for just...
Alcami Announces New Highly Potent API Capabilities and Capacity in Germantown, WI
Friday, August 12, 2016Alcami a leading provider of custom development and manufacturing services for the pharmaceutical and biotechnology industries today announces its plans to expand capabilities for development and manufacturing of Active Pharmaceutical Ingredients API...
Guilin Sanjin Pharmaceutical gets approval to start clinical trial for injection
Thursday, August 11, 2016Guilin Sanjin Pharmaceutical Co Ltd Says it got approval from State Food and Drug Administration to start clinical trial for the injectionNo L Says the injection is for the treatment of colorectal cancer as well as head and neck cancer
